Store launching soon — browse the catalog and join the waitlist to be notified at launch.
✦Canada Post Xpress1–2 day delivery across CanadaFree on orders over $200
Store launching soon — browse the catalog and join the waitlist to be notified at launch.
Your cart is empty
Growth Hormone Fragment
Also known as hGH fragment 176–191
AOD-9604 is a synthetic peptide corresponding to the C-terminal fragment (176–191) of human growth hormone, studied in research for lipolytic-pathway activity.
🚀 Launching soon — join the waitlist to be notified when this product is available.
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
AOD-9604 is a synthetic peptide corresponding to the C-terminal fragment (176–191) of human growth hormone, studied in research for lipolytic-pathway activity.
Experimental models examine its influence on fat metabolism without the growth-promoting signaling of full-length GH.
Third-party tested for purity, ID, quantity.
AOD-9604 reproduces the lipolytic domain of human growth hormone while lacking the regions associated with insulin-like growth effects. Research has examined its action on lipid metabolism, including stimulation of lipolysis and inhibition of lipogenesis in cellular and animal models.
Studies have also evaluated its profile in cartilage and joint research models under structured conditions.
AOD-9604 was developed from research mapping the lipolytic activity of growth hormone to its C-terminal fragment. The synthetic peptide was characterized to retain fat-metabolism activity independent of GH receptor growth signaling.
Subsequent studies investigated metabolic and musculoskeletal research applications.
Research into AOD-9604 focuses on lipid-metabolism and GH-fragment models. Frameworks evaluate lipolytic and antilipogenic signaling and musculoskeletal endpoints under controlled in vitro and preclinical conditions.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each unit contains the labeled quantity of aod 9604. Independent third-party analysis verifies purity, identity, and net content per batch.
The unit contains only the research compound. Any laboratory materials required for reconstitution or experimental procedures must be sourced separately.
Duration depends entirely on research design, storage conditions, and laboratory protocol.
Related
5-Amino-1MQ is a small-molecule research compound studied as an inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme involved in cellular metabolic regulation.
$80.00
Studied in metabolic research for its effects on glucose regulation, appetite signaling, and energy balance.
From$70.00
Dual incretin receptor agonist studied for glucose regulation, metabolic signaling, and weight pathway research
From$50.00
Immune-modulating peptide studied for T-cell signaling and immune system regulatory pathway research
From$60.00
